To identify growth opportunities in the cancer stem cell therapeutics market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2018-2023. Asia, Europe, and North America will grow faster than the overall cancer stem cell market.
Some of the key findings from our cancer stem cell therapeutics market forecast report are summarized below:
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global Cancer Stem Cell Therapeutics Industry Overview
The growing prevalence of cancer across the world is encouraging vendors in the cancer stem cell market to develop novel cancer stem cell therapeutics. The market is expected to witness the launch of many drugs during the forecast period. Several vendors in the cancer stem cell market are developing orally-administered drugs to inhibit cancer stemness pathways by targeting signal transducer and activator of transcription 3 (STAT 3) to treat pancreatic cancer. Many such cancer stem cell therapies are currently in Phase III of clinical trials and are expected to be launched during the forecast period. The strong pipeline in the development of novel cancer stem cell therapies is expected to drive the growth of global cancer stem cell therapeutics market size over the forecast period.
The availability of stem cell markers in the identification of cancer stem cells is one of the key trends influencing cancer stem cell market growth. Cervical cancer is one of the most common causes of death among women. The heterogeneity in cervical carcinoma makes the identification of cancer stem cells challenging. However, the availability of stem cell markers has facilitated the identification of cancer stem cells in various cancer types such as cervical cancer and breast cancer. The advent of stem cell markers is expected to increase the identification and diagnosis rate of various cancer types. This will lead to an increase in the demand for cancer stem cell therapeutics. As a result of these factors, the global cancer stem cell therapeutics market is expected to grow at a CAGR of over 11% during the forecast period.
Top Cancer Stem Cell Therapeutics Companies Covered in This Market Research Report
The global cancer stem cell therapeutics market is fairly concentrated. To help clients improve their market position, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this cancer stem cell market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.
The report offers a detailed analysis of several cancer stem cell therapeutics companies, including:
- Cellerant Therapeutics, Inc.
- Celularity Inc.
- Gamida Cell Ltd.
- Nohla Therapeutics, Inc.
- Sumitomo Dainippon Pharma Co. Ltd.
Cancer Stem Cell Therapeutics Market Segmentation Based on Type
- Allogeneic stem cell transplant
- Autologous stem cell transplant
Allogeneic stem cell transplant is the most commonly used cancer stem cell therapy type. The availability of various approved allogeneic stem cell transplants for the treatment of cancer is driving the growth of the segment. Additionally, there are several stem cell transplants under development that are expected to receive approval during the forecast period.
Cancer Stem Cell Therapeutics Market Segmentation Based on Geography
- Asia
- Europe
- North America
- ROW
North America offers many growth opportunities for cancer stem cell therapy companies. The increase in the number of new cases of leukemia in the region is encouraging many vendors to develop novel therapies that target cancer stem cells. Moreover, the growing prevalence of cancer in the US is contributing to the growth of the cancer stem cell therapeutics market size in North America.
Key Highlights of the Global Cancer Stem Cell Therapeutics Market for the Forecast Period 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the cancer stem cell therapy market size during the next five years
- Precise estimation of the global cancer stem cell therapeutics market share, size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the cancer stem cell therapeutics industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of cancer stem cell therapy companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch